Search Results - "R TOUCHETTE, DANIEL"

Economic Evaluations of Clinical Pharmacy Services: 2006-2010 by Touchette, Daniel R., Doloresco, Fred, Suda, Katie J., Perez, Alexandra, Turner, Stuart, Jalundhwala, Yash, Tangonan, Maria C., Hoffman, James M.

“…Studies have consistently evidenced the positive clinical, economic, and humanistic benefits of pharmacist‐directed patient care in a variety of settings…”
Get full text

Cost-effectiveness analysis of emergency department-based hepatitis C screening and linkage-to-care program by Choi, Sun A, Umashankar, Kandavadivu, Maheswaran, Anjana, Martin, Michelle T, Lee, Jean, Odishoo, Matt, Lin, Janet Y, Touchette, Daniel R

“…In the United States (US), hepatitis C virus (HCV) screening is not covered by payers in settings outside of primary care. A non-traditional, emergency…”
Get full text

Cost evaluation of a nurse coordinated outpatient parenteral antimicrobial therapy (OPAT) program by Deng, Huiwen, Gross, Alan E, Trotter, Andrew B, Touchette, Daniel R

“…A structured, nurse-driven outpatient parenteral antimicrobial therapy (OPAT) program within an academic healthcare system was associated with reduced odds of…”
Get full text

Cost-effectiveness analysis of lumacaftor and ivacaftor combination for the treatment of patients with cystic fibrosis in the United States by Sharma, Dolly, Xing, Shan, Hung, Yu-Ting, Caskey, Rachel N, Dowell, Maria L, Touchette, Daniel R

“…Lumacaftor/ivacaftor was approved by the Food and Drug Administration (FDA) as a combination treatment for Cystic Fibrosis (CF) patients who are homozygous for…”
Get full text

Safety-focused medication therapy management: A randomized controlled trial by Touchette, Daniel R., PharmD, MA, Masica, Andrew L., MD, MSCI, Dolor, Rowena J., MD, MHS, Schumock, Glen T., PharmD, MBA, PhD, Choi, Young Ku, PhD, Kim, Yoonsang, PhD, Smith, Scott R., PhD

“…Objective To evaluate the effect of a medication therapy management (MTM) intervention on adverse drug events (ADEs), health care visits, and drug-related…”
Get full text

Design of a trial to evaluate the impact of clinical pharmacists and community health promoters working with African-Americans and Latinos with diabetes by Gerber, Ben S, Rapacki, Lauren, Castillo, Amparo, Tilton, Jessica, Touchette, Daniel R, Mihailescu, Dan, Berbaum, Michael L, Sharp, Lisa K

“…Given the increasing prevalence of diabetes and the lack of patients reaching recommended therapeutic goals, novel models of team-based care are emerging…”
Get full text

National drug shortages worsen during COVID-19 crisis: Proposal for a comprehensive model to monitor and address critical drug shortages by Piatek, Olga Iwona, Ning, James Chien-min, Touchette, Daniel R

“…In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after…”
Get full text

Adherence patterns 1 year after initiation of SGLT2 inhibitors: results of a national cohort study by Huang, Hsiao-Ching, Touchette, Daniel R, Tadrous, Mina, Schumock, Glen T, Awadalla, Saria, Lee, Todd A

“…Adherence to medications is important for the management of chronic diseases. Although the proportion of days covered (PDC) is a common metric for measuring…”
Get full text

Cost-Effectiveness Analysis of a Pharmacist-Led Medication Therapy Management Program: Hypertension Management by Schultz, Bob G., Tilton, Jessica, Jun, Julie, Scott-Horton, Tiffany, Quach, Danny, Touchette, Daniel R.

“…Uncontrolled hypertension is a common cause of cardiovascular disease, which is the deadliest and costliest chronic disease in the United States. Pharmacists…”
Get full text

Cost-effectiveness of a pharmacist-led medication therapy management clinic for management of type 2 diabetes by Joshi, Mrinmayee, Pham, Christine, Deng, Huiwen, Mathew, Sheryl, Norton, Rachel M., Kim, Kibum, Touchette, Daniel R., Tilton, Jessica J.

“…Diabetes imposes a substantial public health burden. Involvement of clinical pharmacists in diabetes disease management can improve health outcomes while…”
Get full text

Cost-effectiveness of eculizumab and efgartigimod for the treatment of anti-acetylcholine receptor antibody-positive generalized myasthenia gravis by Lien, Pei-Wen, Joshi, Mrinmayee, Tice, Jeffrey A, Agboola, Foluso, Nikitin, Dmitriy, Withanawasam, Vinura, Jatoi, Saira, Touchette, Daniel R

“…Eculizumab and efgartigimod were approved to treat anti-acetylcholine receptor antibody-positive generalized myasthenia gravis (anti-AChR Ab-positive gMG)…”
Get full text

The effectiveness and value of eculizumab and efgartigimod for generalized myasthenia gravis by Tice, Jeffrey A, Touchette, Daniel R, Lien, Pei-Wen, Agboola, Foluso, Nikitin, Dmitriy, Pearson, Steven D

“…Funding for this summary was contributed by Arnold Ventures, The Donaghue Foundation, Harvard Pilgrim Health Care, and Kaiser Foundation Health Plan to the…”
Get more information

Cost-Effectiveness of Nadofaragene Firadenovec and Pembrolizumab in Bacillus Calmette-Guérin Immunotherapy Unresponsive Non–Muscle Invasive Bladder Cancer by Joshi, Mrinmayee, Atlas, Steven J., Beinfeld, Molly, Chapman, Richard H., Rind, David M., Pearson, Steven D., Touchette, Daniel R.

“…Nadofaragene firadenovec is a gene therapy for bacillus Calmette-Guérin (BCG)–unresponsive non–muscle-invasive bladder cancer (NMIBC) undergoing Food and Drug…”
Get full text

Prompt initiation of triple therapy following hospitalization for a chronic obstructive pulmonary disease exacerbation in the United States: An analysis of the PRIMUS study by Evans, Kristin A, Pollack, Michael, Portillo, Edward, Strange, Charlie, Touchette, Daniel R, Staresinic, Anthony, Patel, Sushma, Tkacz, Joseph, Feigler, Norbert

“…Severe exacerbations requiring hospitalization contribute a substantial portion of the morbidity and costs of chronic obstructive pulmonary disease (COPD)…”
Get full text

Medications for obesity management: Effectiveness and value: A summary from the Institute for Clinical and Economic Review’s New England Comparative Effectiveness Public Advisory Council by Atlas, Steven J, Kim, Kibum, Nhan, Emily, Touchette, Daniel R, Moradi, Ashton, Agboola, Foluso, Rind, David M, Beaudoin, Francesca L, Pearson, Steven D

Get full text

Drug Errors and Related Interventions Reported by United States Clinical Pharmacists: The American College of Clinical Pharmacy Practice-Based Research Network Medication Error Detection, Amelioration and Prevention Study by Kuo, Grace M., Touchette, Daniel R., Marinac, Jacqueline S.

“…Objective To describe and evaluate drug errors and related clinical pharmacist interventions. Design Cross‐sectional observational study with an online data…”
Get full text

Cost-Effectiveness of Strategies to Personalize the Selection of P2Y12 Inhibitors in Patients with Acute Coronary Syndrome by Kim, Kibum, Touchette, Daniel R., Cavallari, Larisa H., Ardati, Amer K., DiDomenico, Robert J.

“…Purpose Perform a cost-effectiveness analysis comparing strategies for selecting P2Y 12 inhibitors in acute coronary syndrome (ACS). Methods Six strategies for…”
Get full text

Cost‐Effectiveness Analysis of Sacubitril/Valsartan for the Treatment of Heart Failure with Reduced Ejection Fraction in the United States by Zueger, Patrick M., Kumar, Varun M., Harrington, Rachel L., Rigoni, Gianna C., Atwood, Alicia, DiDomenico, Robert J., Touchette, Daniel R.

“…Objective Sacubitril/valsartan (SAC/VAL) has been shown to reduce mortality and hospitalization in patients with heart failure with reduced ejection fraction…”
Get full text

PRIMUS - Prompt Initiation of Maintenance Therapy in the US: A Real-World Analysis of Clinical and Economic Outcomes Among Patients Initiating Triple Therapy Following a COPD Exacerbation by Tkacz, Joseph, Evans, Kristin A, Touchette, Daniel R, Portillo, Edward, Strange, Charlie, Staresinic, Anthony, Feigler, Norbert, Patel, Sushma, Pollack, Michael

“…Patients with chronic obstructive pulmonary disease (COPD) may experience moderate (requiring outpatient care) or severe (requiring hospitalization) disease…”
Get full text

Community Health Workers Supporting Clinical Pharmacists in Diabetes Management: A Randomized Controlled Trial by Sharp, Lisa K., Tilton, Jessica J., Touchette, Daniel R., Xia, Yinglin, Mihailescu, Daniel, Berbaum, Michael L., Gerber, Ben S.

“…Objectives To evaluate the effectiveness of clinical pharmacists and community health workers (CHWs) in improving glycemic control within a low‐income ethnic…”
Get full text